COMMUNIQUÉS West-GlobeNewswire

Report on transactions with ALK-Abelló A/S B shares and associated securities by managerial staff
21/02/2025
ALK ( ALKB:DC / OMX: ALK B / AKBLF ): In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation), ALK-Abelló A/S shall report the following transactions [...]
Singular Genomics Announces Closing of Acquisition by Deerfield Management
21/02/2025
SAN DIEGO, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and [...]
Ipsen S.A. publishes its 2024 consolidated financial statements
21/02/2025
Ipsen S.A. - 2024 Consolidated Financial Statements Attachment Ipsen_Consolidated financial statements 2024_EN
Ipsen S.A. publie ses comptes consolidés 2024
21/02/2025
Ipsen S.A. - Etats financiers consolidés 2024 Pièce jointe Ipsen_Comptes Consolidés 2024_FR
Correction: Aino Health year-end report January-December 2024
21/02/2025
Correction: The reason for the correction is that the previous mailing did not contain the attached report. This document in English is a translation of the original in Swedish. In case of any discrepancy, the Swedish [...]
Marius Pharmaceuticals Unveils New Corporate Website and Announces Longevity & Endocrinology Advisory Boards
21/02/2025
RALEIGH, N.C., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals , a biopharmaceutical company dedicated to redefining the treatment of testosterone deficiency, is excited to announce the launch of its new [...]
Amwell® makes grants to new employees under inducement plan
21/02/2025
BOSTON, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading technology-enabled care platform provider, announced that on Feb. 18, Amwell made grants of RSUs covering an aggregate of 16,737 shares of its [...]
Ensho Therapeutics Announces Presentation of Data Highlighting NSHO-101 as a Once-Daily Oral Agent for the Potential Treatment of Inflammatory Bowel Disease at ECCO 2025
21/02/2025
MORRIS PLAINS, N.J., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Ensho Therapeutics, Inc., a privately held, clinical-stage biopharmaceutical company focused on developing breakthrough oral therapies for patients with [...]
Biostax Corp Announces Voluntary Delisting from OTC Pink Market and SEC Deregistration
21/02/2025
ORLANDO, Fla., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Biostax Corp (OTC Pink: BIOX) ("Biostax" or "the Company"), a biopharmaceutical company focused on developing innovative immune restoration therapies, today announced its [...]
Longeveron® to Report Full Year 2024 Financial Results and Host Conference Call on February 28, 2025
21/02/2025
MIAMI, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related [...]
Tempus and Stemline Therapeutics, Inc., A Subsidiary of the Menarini Group, Announce Collaboration to Implement Tempus Next, an AI-Enabled Care Pathway Intelligence Platform to Support Patients with Metastatic Breast Cancer
21/02/2025
Up to 50% of patients with ER+/HER2- mBC could develop ESR1 mutations as a result of prior exposure to endocrine therapy in the metastatic setting. Testing to identify these mutations can help clinicians support more [...]
Neuronetics to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call
21/02/2025
MALVERN, Pa., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who [...]
Inozyme Pharma to Present Recently Announced Interim Data for INZ-701 in Infants and Young Children with ENPP1 Deficiency at CHOP Cardiology 2025
21/02/2025
BOSTON, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) (“the Company” or “Inozyme”), a clinical-stage biopharmaceutical company developing innovative therapeutics for rare diseases that affect [...]
Wellgistics Health, Inc. Announces Pricing of $4.0 Million Initial Public Offering
21/02/2025
Tampa, Florida, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Wellgistics Health, Inc. (the "Company"), a holding company for various existing and planned strategic businesses centered around healthcare technology and [...]
Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2024 Financial Results
21/02/2025
Fourth quarter 2024 CAPLYTA net product sales grew to $199.2 million , representing a 51% increase over the same period in 2023 Full year 2024 CAPLYTA net product sales were $680.5 million , representing year-over-year [...]
Ocugen to Host Conference Call on Wednesday, March 5, 2025 at 8:30 A.M. ET to Discuss Business Updates and Fourth Quarter and Full Year 2024 Financial Results
21/02/2025
MALVERN, Pa., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, [...]
Firefly Neuroscience Announces Exercise of Warrants for Total Proceeds of $8.8 Million
21/02/2025
Extends cash runway well into mid-2026; no new/replacement warrants issued KENMORE, N.Y., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly,” or the “Company”) (NASDAQ: AIFF), an Artificial [...]
NKGen Biotech Announces Administration of First Dose of Troculeucel to Frontotemporal Dementia Patient Under FDA-Cleared Compassionate Use Program
21/02/2025
NKGen takes a meaningful step towards potential treatment for frontotemporal dementia (“FTD”) patients with limited treatment options. SANTA ANA, Calif., Feb. 21, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (Nasdaq: [...]
Madrigal Pharmaceuticals to Participate in the 45th Annual TD Cowen Health Care Conference
21/02/2025
CONSHOHOCKEN, Pa., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) today announced that the company will participate in the 45th Annual TD Cowen Health Care Conference on Tuesday, March 4 [...]

Pages